Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of SR-0379 in Patients With Skin Ulcers Requiring Wound Bed Preparation
jRCT2011240068Phase 3Recruiting
- Sponsor
- FunPep
- Start
- Mar 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cutaneous ulcer comparing SR-0379 spray with Placebo spray (2 arms). Primary endpoint: Days to minor surgical intervention. Started Mar 2025; status: recruiting.
02
Drugs
SR-0379
03
Conditions
Cutaneous ulcer
Beyond the preview
Go deeper on jRCT2011240068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011240068.